Skip to main content Skip to footer
American Family Children's Hospital
SHARE TEXT
 
Carey E. Gleason, PhD close
Carey E. Gleason, PhD

New Patients

Need help selecting a primary care doctor? Contact the Welcome Center for personal assistance.

For Referring Physicians

How to refer a patient

Carey E. Gleason, PhD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Carey E. Gleason, PhD completed her education at the California School of Professional Psychology.

Specialties

Clinics

University Station Clinic
(608) 263-7740 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital
Veterans Hospital - Wm. S. Middleton Memorial

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Education California School of Professional Psychology, Fresno, CA
Fellowship

Geropsychology Fellowship, Loius Stokes Cleveland Veterans Administrations Medical Center, Cleveland, OH; Neuropsychology Fellowship; University of Washington, Geriatric Research, Education and Clinical Center (GRECC), Tacoma, WA



Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Gilmore-Bykovskyi AL Block LM Walljasper L Hill N Gleason C Shah MN Unstructured clinical documentation reflecting cognitive and behavioral dysfunction: toward an EHR-based phenotype for cognitive impairment. J Am Med Inform Assoc . 2018 Sep 1;25(9):1206-1212
[PubMed ID: 29947805]
Umucu E Wyman M Lee B Zuelsdorff M Benton SF Nystrom N Johnson SC Carlsson CM Asthana S Gleason CE Apathy in Preclinical Alzheimer's Disease: Psychometric Validation of the Apathy Evaluation Scale. Am J Alzheimers Dis Other Demen . 2018 Aug 14;:1533317518794020
[PubMed ID: 30103612]
Kantarci K Tosakulwong N Lesnick TG Zuk SM Lowe VJ Fields JA Gunter JL Senjem ML Settell ML Gleason CE Shuster LT Bailey KR Dowling NM Asthana S Jack CR Jr Rocca WA Miller VM Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial. Neurology . 2018 Apr 17;90(16):e1404-e1412
[PubMed ID: 29661902]
Gleason CE Norton D Anderson ED Wahoske M Washington DT Umucu E Koscik RL Dowling NM Johnson SC Carlsson CM Asthana S Alzheimer’s Disease Neuroimaging Initiative. Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker. J Alzheimers Dis . 2018;61(1):79-89
[PubMed ID: 29125485]
Santoro N Allshouse A Neal-Perry G Pal L Lobo RA Naftolin F Black DM Brinton EA Budoff MJ Cedars MI Dowling NM Dunn M Gleason CE Hodis HN Isaac B Magnani M Manson JE Miller VM Taylor HS Wharton W Wolff E Zepeda V Harman SM Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause . 2017 Mar;24(3):238-246
[PubMed ID: 27779568]
Messina M Gleason C Evaluation of the potential antidepressant effects of soybean isoflavones. Menopause . 2016 Dec;23(12):1348-1360
[PubMed ID: 27552470]
Koscik RL Berman SE Clark LR Mueller KD Okonkwo OC Gleason CE Hermann BP Sager MA Johnson SC Intraindividual Cognitive Variability in Middle Age Predicts Cognitive Impairment 8-10 Years Later: Results from the Wisconsin Registry for Alzheimer's Prevention. J Int Neuropsychol Soc . 2016 Nov;22(10):1016-1025
[PubMed ID: 27903330]
Kantarci K Tosakulwong N Lesnick TG Zuk SM Gunter JL Gleason CE Wharton W Dowling NM Vemuri P Senjem ML Shuster LT Bailey KR Rocca WA Jack CR Jr Asthana S Miller VM Effects of hormone therapy on brain structure: A randomized controlled trial. Neurology . 2016 Aug 30;87(9):887-96
[PubMed ID: 27473135]
Racine AM Koscik RL Berman SE Nicholas CR Clark LR Okonkwo OC Rowley HA Asthana S Bendlin BB Blennow K Zetterberg H Gleason CE Carlsson CM Johnson SC Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife. Brain . 2016 Aug;139(Pt 8):2261-74
[PubMed ID: 27324877]
Gleason CE Dowling NM Benton SF Kaseroff A Gunn W Edwards DF Common Sense Model Factors Affecting African Americans' Willingness to Consult a Healthcare Provider Regarding Symptoms of Mild Cognitive Impairment. Am J Geriatr Psychiatry . 2016 Jul;24(7):537-46
[PubMed ID: 26809602]
Anderson ED Wahoske M Huber M Norton D Li Z Koscik RL Umucu E Johnson SC Jones J Asthana S Gleason CE Alzheimer's Disease Neuroimaging Initiative. Cognitive variability-A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (Amst) . 2016;4:47-55
[PubMed ID: 27489880]
Kantarci K Lowe VJ Lesnick TG Tosakulwong N Bailey KR Fields JA Shuster LT Zuk SM Senjem ML Mielke MM Gleason C Jack CR Rocca WA Miller VM Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. J Alzheimers Dis . 2016 May 7;53(2):547-56
[PubMed ID: 27163830]
Hoscheidt SM Starks EJ Oh JM Zetterberg H Blennow K Krause RA Gleason CE Puglielli L Atwood CS Carlsson CM Asthana S Johnson SC Bendlin BB Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults. J Alzheimers Dis . 2016 Apr 12;52(4):1373-83
[PubMed ID: 27079723]
Melah KE Lu SY Hoscheidt SM Alexander AL Adluru N Destiche DJ Carlsson CM Zetterberg H Blennow K Okonkwo OC Gleason CE Dowling NM Bratzke LC Rowley HA Sager MA Asthana S Johnson SC Bendlin BB Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease. J Alzheimers Dis . 2016;50(3):873-86
[PubMed ID: 26836182]
Gleason CE Dowling NM Wharton W Manson JE Miller VM Atwood CS Brinton EA Cedars MI Lobo RA Merriam GR Neal-Perry G Santoro NF Taylor HS Black DM Budoff MJ Hodis HN Naftolin F Harman SM Asthana S Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. PLoS Med . 2015 Jun;12(6):e1001833; discussion e1001833
[PubMed ID: 26035291]
Almeida RP Schultz SA Austin BP Boots EA Dowling NM Gleason CE Bendlin BB Sager MA Hermann BP Zetterberg H Carlsson CM Johnson SC Asthana S Okonkwo OC Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease. JAMA Neurol . 2015 Jun;72(6):699-706
[PubMed ID: 25893879]
Dowling NM Johnson SC Gleason CE Jagust WJ Alzheimer's Disease Neuroimaging Initiative. The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. Neuroimage . 2015 Jan 15;105:357-68
[PubMed ID: 25450107]
Gleason CE Fischer BL Dowling NM Setchell KD Atwood CS Carlsson CM Asthana S Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease. J Alzheimers Dis . 2015;47(4):1009-19
[PubMed ID: 26401779]
Starks EJ Patrick O'Grady J Hoscheidt SM Racine AM Carlsson CM Zetterberg H Blennow K Okonkwo OC Puglielli L Asthana S Dowling NM Gleason CE Anderson RM Davenport-Sis NJ DeRungs LM Sager MA Johnson SC Bendlin BB Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers. J Alzheimers Dis . 2015;46(2):525-33
[PubMed ID: 25812851]
Mielke MM Haughey NJ Bandaru VVR Zetterberg H Blennow K Andreasson U Johnson SC Gleason CE Blazel HM Puglielli L Sager MA Asthana S Carlsson CM Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease. Neurobiol Aging . 2014 Nov;35(11):2486-2494
[PubMed ID: 24952994]